“Impact of HIV Subtype on Response and Resistance in Antiretroviral-naïve Adults Comparing Treatment With Once Daily Versus Twice Daily Ritonavir Boosted Fosamprenavir in Combination With Abacavir Lamivudine”. Drugs and Therapy Studies, vol. 2, no. 1, Dec. 2011, p. e1, https://doi.org/10.4081/dts.2012.e1.